Retinal Disorder Treatment: Core Growth Enabler in the Rising Incidence Of Retinal Disorders Fuels Momentum In The Retinal Disorder Treatment Market Market, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Retinal Disorder Treatment Industry Market Size Be by 2025?
In past years, the retinal disorder treatment market has witnessed significant growth. The market worth which stood at $12.59 billion in 2024, is expected to surge to $13.69 billion in 2025, approximating a compound annual growth rate (CAGR) of 8.7%. Factors contributing to this growth in the historical period include the advent of anti-VEGF therapies, an aging populace, a rising occurrence of retinal disorders, upgraded tools for early diagnosis, enhanced consciousness and screening initiatives, as well as broadened healthcare service accessibility.

What's the Long-Term Growth Forecast for the Retinal Disorder Treatment Market Size Through 2029?
There is an anticipated significant increase in the market size of retinal disorder treatments in the coming years. By 2029, it is predicted to reach a value of $19.3 billion, with a compound annual growth rate (CAGR) of 9.0%. This substantial growth during the forecast period can be credited to more patient-focused methods in retinal health care, a rise in worldwide health care expenses, an increased emphasis on combination therapies for retinal disorders, the emergence of at-home monitoring for retinal disorders, a surge in the use of implantable devices for retinal treatments, and the application of regenerative medicine in retina treatment. Key trends projected during this period include advancements in technology for ophthalmic imaging, the creation of minimally invasive surgical procedures, the incorporation of artificial intelligence in diagnostics, innovations in drug delivery systems, the use of virtual reality in retinal rehabilitation, partnerships between research institutions and pharmaceutical firms, and the evolution of gene therapies to treat genetic retinal diseases.

View the full report here:
https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report

What Are the Key Growth Drivers Fueling the Retinal Disorder Treatment Market Expansion?
The retinal disorder treatment market is anticipated to expand due to the rising prevalence of retinal disorders. These disorders, which affect the retina or the light-sensitive tissue at the rear of the eye, can lead to loss of vision or substantial visual impairment. Treatments for retinal disorders, including laser therapy, vitrectomy, and retinal implants, are effective in managing and decreasing these conditions' symptoms. For example, the UK-based International Agency for the Prevention of Blindness projected in January 2023 that age-related macular degeneration (AMD) would account for around 5% of global blindness. Further, AMD diseases are predicted to affect approximately 288 million individuals by 2040. Hence, the increasing occurrence of retinal disorders is propelling the growth of the retinal disorder treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12701&type=smp

What Trends Will Shape the Retinal Disorder Treatment Market Through 2029 and Beyond?
The retinal disorder treatment market is witnessing a significant trend of product innovations, with major players launching novel products to maintain their market standing. Case in point, the Switzerland-domiciled pharmaceutical firm F. Hoffmann-La Roche AG obtained approval for its bispecific antibody, Vabysmo, from the U.S. Food and Drug Administration (FDA) in January 2022. This medication, which is used for treating neovascular or wet age-related macular degeneration (AMD) and diabetic macular edema (DME), is the pioneering injectable eye treatment that inhibits two disease pathways associated with retinal disorders that can diminish vision. These pathways are angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A (VEGF-A). The clinical trials demonstrated vision enhancements comparable to conventional therapy and were deemed safe. The approval of this treatment marks a substantial progression in retinal disease therapy and gives patients the chance to achieve improved vision and a reduced treatment regimen.

How Is the Retinal Disorder Treatment Market Segmented?
The retinal disorder treatment market covered in this report is segmented -

1) By Type: Macular Degeneration, Diabetic Retinopathy, Other Types
2) By Dosage Form: Gels, Eye Solutions, Capsules And Tablets, Eye Drops, Ointments
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:
1) By Macular Degeneration: Dry Macular Degeneration, Wet Macular Degeneration
2) By Diabetic Retinopathy: Non-Proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy
3) By Other Types: Retinal Detachment, Retinitis Pigmentosa, Uveitis, Other Retinal Disorders

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12701&type=smp

Which Companies Are Leading the Charge in Retinal Disorder Treatment Market Innovation?
Major companies operating in the retinal disorder treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Takeda Pharmaceutical Company Limited, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Genentech Inc., Santen Pharmaceutical Co. Ltd., Apellis Pharmaceuticals Inc., Kubota Pharmaceutical Holdings Co. Ltd, Alimera Sciences Inc., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Adverum Biotechnologies Inc., Kodiak Sciences Inc., Acucela Inc., IVERIC bio Inc., Oxurion NV, Graybug Vision Inc., Icon Bioscience Inc., Clearside Biomedical Inc., Aerpio Pharmaceuticals Inc., Neurotech Pharmaceuticals Inc., Ophthotech Corporation, Opthea Limited, PanOptica Inc., ThromboGenics NV

Which Regions Are Leading the Global Retinal Disorder Treatment Market in Revenue?
North America was the largest region in the retinal disorder treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the retinal disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12701

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.